PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
Raoud Marayati(University of Alabama at Birmingham), Elizabeth A. Beierle(Children's of Alabama)
Cited by 12
Related Papers
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
|Oncotarget|2018|30
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
|PLoS ONE|2013|29
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
|Scientific Reports|2018|24
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
|PLoS ONE|2019|15
Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype
|Journal of Pediatric Surgery|2023|3